Consumer: Weighing Pradaxa’s Risks

Monday, August 18, 2014 - 17:30 in Health & Medicine

Despite recent sharp criticism and a $650 million settlement, hundreds of thousands of consumers with atrial fibrillation continue to take the blood thinner.

Read the whole article on NY Times Health

More from NY Times Health

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net